CVS Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CVS Health generated cash of $13,426,000,000, which is less than the previous year. Cash used in financing activities reached the amount of $2,683,000,000 last year. Net change in cash is therefore -$4,780,000,000.
Cash Flow
| 2014 | 8.13B | -4.04B | -5.69B |
|---|---|---|---|
| 2015 | 8.53B | -13.42B | 4.87B |
| 2016 | 10.06B | -2.47B | -6.68B |
| 2017 | 8.00B | -2.87B | -6.75B |
| 2018 | 8.86B | -43.28B | 36.81B |
| 2019 | 12.84B | -3.33B | -7.65B |
| 2020 | 15.86B | -5.53B | -7.69B |
| 2021 | 18.26B | -5.26B | -11.35B |
| 2022 | 16.17B | -5.04B | -10.51B |
| 2023 | 13.42B | -20.88B | 2.68B |
CVS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.30B | 12.69B | 11.04B | 5.95B | 6.55B | 1.9B | 3.52B | 2.45B | 2.48B | 4.08B |
Operating activities | ||||||||||
Net income | 8.36B | 4.32B | 7.89B | 7.19B | 6.63B | -596M | 6.62B | 5.31B | 5.23B | 4.64B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.36B | 4.22B | 4.51B | 4.44B | 4.37B | 2.71B | 2.47B | 2.47B | 2.09B | 1.93B |
Stock-based compensation expense | 588M | 447M | 484M | 400M | 453M | 280M | 234M | 222M | 230M | 165M |
| Deferred income tax benefit | 588M | 447M | 484M | 400M | 453M | 280M | 234M | 222M | 230M | 165M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -6.26B | -2.97B | -2.70B | -1.51B | -2.15B | -1.13B | -941M | -243M | -1.59B | -737M |
Inventories | 1.23B | -1.43B | 735M | -973M | -1.07B | -1.15B | -514M | -742M | -1.14B | -770M |
Accounts payable | 3.61B | 4.26B | 2.89B | 2.76B | 3.55B | 2.48B | 1.71B | 2.18B | 2.83B | 1.74B |
Cash generated by operating activities | 13.42B | 16.17B | 18.26B | 15.86B | 12.84B | 8.86B | 8.00B | 10.06B | 8.53B | 8.13B |
Investing activities | ||||||||||
Purchases Of Investments | -9.04B | -7.74B | -9.96B | -9.63B | -7.53B | -692M | -137M | -65M | -267M | -157M |
Investments In Property Plant And Equipment | -3.03B | -2.72B | -2.52B | -2.43B | -2.45B | -2.03B | -1.91B | -2.22B | -2.36B | -2.13B |
Acquisitions Net | -16.61B | -1.38B | -146M | -26M | -444M | -41.39B | -1.18B | -539M | -11.47B | -2.43B |
Cash generated by investing activities | -20.88B | -5.04B | -5.26B | -5.53B | -3.33B | -43.28B | -2.87B | -2.47B | -13.42B | -4.04B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 549M | 264M | 0 | 242M | 0 | 5.55B | 0 | 2.58B |
Payments for dividends | -3.13B | -2.90B | -2.62B | -2.62B | -2.60B | -2.03B | -2.04B | -1.84B | -1.57B | -1.28B |
Repurchases of common stock | -2.01B | -3.5B | -168M | -88M | 0 | -97M | -4.36B | -4.46B | -5.00B | -4.00B |
Repayments of term debt | 7.93B | -4.21B | -10.25B | -5.67B | -5.32B | -6.07B | -598M | -5.94B | 11.21B | -3.1B |
Cash used in financing activities | 2.68B | -10.51B | -11.35B | -7.69B | -7.65B | 36.81B | -6.75B | -6.68B | 4.87B | -5.69B |
Net Change In Cash | -4.78B | 614M | 1.64B | 2.17B | 1.85B | 2.39B | -1.62B | 912M | -22M | -1.60B |
Cash at end of period | 8.52B | 13.30B | 12.69B | 8.13B | 8.40B | 4.29B | 1.9B | 3.37B | 2.45B | 2.48B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |